Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
et al., 2017, Thromboelastography (TEG®) demonstrates that tinzaparin 4500 international units has no detectable anticoagulant activity after caesarean section., Int J Obstet Anesth, Vol:29, Pages:50-56
Randi AM, Laffan MA, 2017, Von Willebrand factor and angiogenesis: basic and applied issues., J Thromb Haemost, Vol:15, Pages:13-20
et al., 2017, Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia., Blood, Vol:129, Pages:520-524
et al., 2017, Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity., Nature, Vol:541, Pages:81-86
et al., 2016, Use of long term prophylaxis in London haemophilia centres, Haemophilia, Vol:22, ISSN:1351-8216, Pages:110-110